跳至主要内容
临床试验/IRCT2016021125732N2
IRCT2016021125732N2已完成2 期

Clinical and laboratory Efects of vitamin D supplementation in adolescent with polycystic ovarian syndrome and vitamin D deficiency

Vice Chancellor for Research, Semnan University of Medical sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
80 years 至 76 years(—)
性别
Female

入选标准

  • age 14 to 18 years old; people with impaired ovulation or anovulation for oligoovulation (oligo- and / or anovulation); 2 and 3 Hyperandrogenemia clinical hyperandrogenism or There polycystic ovarian morphology on ultrasound and they are deficient in vitamin D, and the study Azargoon et al(1) known as polycystic ovarian syndrome.
  • Exclusion criteria: people who do not have full consent to participate in this study; Those who did not use vitamin D to regular weekly; Those in the intervention of the symptoms of polycystic ovary syndrome drugs such as birth control pills, metformin, medroxyprogesterone and progesterone intramuscular injection except in the event of amenorrhea has 45 days from the previous cycle dose of 200 mg for the induction periods are used.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Semnan University of Medical sciences

相似试验